Sen. Jack Reed bought Thermo Fisher Scientific (TMO)
Sen. Jack Reed (D-RI) · $1K–$15K · traded Mar 6, 2017
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Mar 6, 2017
- Disclosed
- Mar 7, 2017
- Days to disclose
- 1
- Asset type
- Stock
- As filed
- Thermo Fisher Scientific Inc.
- Industry
- Medical - Diagnostics & Research · Healthcare
Other trades in this filing
- Mar 7, 2017$1K–$15K
$1K–$15K · Traded Mar 6, 2017 · disclosed Mar 7, 2017 · Joint
- Mar 7, 2017$1K–$15K
Bought State Street SPDR S&P Biotech ETF XBI
$1K–$15K · Traded Mar 6, 2017 · disclosed Mar 7, 2017 · Joint
- Mar 7, 2017$1K–$15K
$1K–$15K · Traded Mar 6, 2017 · disclosed Mar 7, 2017 · Joint
- Mar 7, 2017$1K–$15K
$1K–$15K · Traded Mar 6, 2017 · disclosed Mar 7, 2017 · Joint
Recent Congress trades in TMO
- Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Sold Thermo Fisher Scientific TMO
$1K–$15K · Traded Dec 12, 2024 · disclosed Aug 7, 2026 · filed 603 days later
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Bought Thermo Fisher Scientific TMO
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 17, 2026$1K–$15K
Rep. Dan Newhouse (R-WA-4)
Sold Thermo Fisher Scientific TMO
$1K–$15K · Traded Jul 10, 2026 · disclosed Jul 17, 2026 · Spouse
Traded 13 days before earnings - May 15, 2026$1K–$15K
Rep. Dwight Evans (D-PA-3)
Sold (partial) Thermo Fisher Scientific TMO
$1K–$15K · Traded May 7, 2026 · disclosed May 15, 2026
- May 11, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
Bought Thermo Fisher Scientific TMO
$15K–$50K · Traded Apr 13, 2026 · disclosed May 11, 2026 · Spouse
- Feb 6, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
Sold Thermo Fisher Scientific TMO
$15K–$50K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
Bought Thermo Fisher Scientific TMO
$1K–$15K · Traded Jul 25, 2025 · disclosed Jan 13, 2026 · filed 172 days later
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
Sold Thermo Fisher Scientific TMO
$1K–$15K · Traded Apr 28, 2025 · disclosed Jan 13, 2026 · filed 260 days later
Company context for TMO
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
TMO: Leadership change
Filed 8-K for an event or period dated 2026-10-27. Leadership change.
TMO: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-26. Read the company report for its disclosures.
TMO: Financial results
Filed 8-K for an event or period dated 2026-10-21. Financial results.
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.